Literature DB >> 14675476

Total and allergen-specific IgE levels in serum reflect blood eosinophilia and fractional exhaled nitric oxide concentrations but not pulmonary functions in allergic asthmatic children sensitized to house dust mites.

Oliviero Sacco1, Rosa Sale, Michela Silvestri, Laura Serpero, Federica Sabatini, Maria E Raynal, Maurizio Biraghi, Giovanni A Rossi.   

Abstract

Although elevated levels of serum immunoglobulin E (IgE) are considered the hallmark of atopic diseases, their clinical value in evaluating subjects with allergic disorders is under debate. To evaluate possible relationships between serum IgE levels and a variety of clinical parameters, 83 mild asthmatic children [10.98-year-old (2.95)], sensitized to house dust mites (HDM) Dermatophagoides pteronyssinus (Dp) or D. farinae (Df), were enrolled. As compared with normal control reference values detected in our laboratory, children with allergic asthma had higher blood eosinophil counts (expressed both as percentage and as absolute number) and higher fractional exhaled nitric oxide (FeNO) levels but similar values in pulmonary function parameters. In the allergic asthmatic population, serum levels of total, Dp-specific or Df-specific IgE correlated positively with eosinophil counts (Rho > or = 0.30, p < 0.01, each correlation) and FeNO levels (Rho > or = 0.33, p < 0.01, each correlation) but not with pulmonary function parameters (p > 0.1, each correlation). Finally, significant correlations, although moderate, were found in the allergic asthmatic population between eosinophil counts and FeNO levels (Rho > or = 0.42, p < 0.001, each correlation). Thus, in atopic children sensitized to HDM with mild intermittent asthma, IgE levels in blood appear to reflect systemic (blood eosinophils) and organ-specific (FeNO) markers of allergic inflammation but not pulmonary volumes or the degree of airflow limitation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14675476     DOI: 10.1046/j.0905-6157.2003.00092.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  7 in total

1.  Population-based efficacy modeling of omalizumab in patients with severe allergic asthma inadequately controlled with standard therapy.

Authors:  Rui Zhu; Yanan Zheng; Wendy S Putnam; Jennifer Visich; Mark D Eisner; John G Matthews; Karin E Rosen; David Z D'Argenio
Journal:  AAPS J       Date:  2013-02-15       Impact factor: 4.009

2.  Relationship between longitudinal changes in type-2 inflammation, immunoglobulin E sensitization, and clinical outcomes in young asthmatics.

Authors:  Nikolaos Tsolakis; Tiago Jacinto; Christer Janson; Magnus Borres; Andrei Malinovschi; Kjell Alving
Journal:  Clin Transl Allergy       Date:  2021-09       Impact factor: 5.657

3.  Clinical patterns in asthma based on proximal and distal airway nitric oxide categories.

Authors:  James L Puckett; Richard W E Taylor; Szu-Yun Leu; Olga L Guijon; Anna S Aledia; Stanley P Galant; Steven C George
Journal:  Respir Res       Date:  2010-04-28

Review 4.  Partitioned exhaled nitric oxide to non-invasively assess asthma.

Authors:  James L Puckett; Steven C George
Journal:  Respir Physiol Neurobiol       Date:  2008-07-31       Impact factor: 1.931

5.  Factors attributable to the level of exhaled nitric oxide in asthmatic children.

Authors:  P Banovcin; M Jesenak; Z Michnova; E Babusikova; S Nosal; J Mikler; J Fabry; M Barreto
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

6.  Relationship between atopy and bronchial hyperresponsiveness.

Authors:  Dong In Suh; Young Yull Koh
Journal:  Allergy Asthma Immunol Res       Date:  2013-02-27       Impact factor: 5.764

7.  Establishing IMMULITE® 2000 cut-off values for serum allergen-specific immunoglobulin and exploring their relationship to exhaled nitric oxide.

Authors:  Bjørg Evjenth; Tonje E Hansen; Ole-Lars Brekke; Jan Holt
Journal:  Acta Paediatr       Date:  2014-03-31       Impact factor: 2.299

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.